We then asked, ‘What epileptogenic mechanisms are present in GFAP overlap-syndrome patients, and which antibodies reflect a dominant role?’ However, the specific mechanisms underlying these effects remain unclear. Here, GFAP is linked to overlapping connective tissue disease.